12:00 AM
May 27, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Apricus Biosciences completes follow-on

Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif.
Business: Drug delivery, Genitourinary, Cancer
Date completed: 5/23/13
Type: Follow-on

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >